Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings (NCT05074524) | Clinical Trial Compass
CompletedNot Applicable
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
United States24 participantsStarted 2021-10-06
Plain-language summary
The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.
Who can participate
Age range18 Years – 64 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult aged 18-64, used heroin in the past 30 days;
* has a history of heroin use for at least one year;
* meets the clinical criteria for Opioid Use Disorder (only heroin use will be considered to meet this criteria);
* meets the clinician clearance using the rTMS Patient Screening Form.
Exclusion Criteria:
* do not currently take and medications for a substance use disorder such as methadone, buprenorphine, naltrexone, acamprosate, disulfiram;
* do not have a psychotic disorder;
* do not have a diagnosis of another substance use disorder;
* do not have a history of seizures or other neurological disorders including organic brain disease; epilepsy, stroke, brain lesions, multiple sclerosis, previous neurosurgery;
* do not have a personal history of head trauma that resulted in a loss of consciousness for more than 5 minutes and retrograde amnesia for more than 30 minutes;
* do not have a presence of non-fixed metal in body 30 cm to treatment coil.
* have not taken any medication for a substance use disorder within the last 72 hours before the first rTMS treatment;
* are not pregnant or think you may be pregnant.